Cargando…

Investigation of the enantioselectivity of acetylcholinesterase and butyrylcholinesterase upon inhibition by tacrine-iminosugar heterodimers

The copper-catalysed azide-alkyne cycloaddition was applied to prepare three enantiomeric pairs of heterodimers containing a tacrine residue and a 1,4-dideoxy-1,4-imino-D-arabinitol (DAB) or 1,4-dideoxy-1,4-imino-L-arabinitol (LAB) moiety held together via linkers of variable lengths containing a 1,...

Descripción completa

Detalles Bibliográficos
Autores principales: Vaaland, I. Caroline, López, Óscar, Puerta, Adrián, Fernandes, Miguel X., Padrón, José M., Fernández-Bolaños, José G., Sydnes, Magne O., Lindbäck, Emil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9721440/
https://www.ncbi.nlm.nih.gov/pubmed/36458374
http://dx.doi.org/10.1080/14756366.2022.2150762
_version_ 1784843776161742848
author Vaaland, I. Caroline
López, Óscar
Puerta, Adrián
Fernandes, Miguel X.
Padrón, José M.
Fernández-Bolaños, José G.
Sydnes, Magne O.
Lindbäck, Emil
author_facet Vaaland, I. Caroline
López, Óscar
Puerta, Adrián
Fernandes, Miguel X.
Padrón, José M.
Fernández-Bolaños, José G.
Sydnes, Magne O.
Lindbäck, Emil
author_sort Vaaland, I. Caroline
collection PubMed
description The copper-catalysed azide-alkyne cycloaddition was applied to prepare three enantiomeric pairs of heterodimers containing a tacrine residue and a 1,4-dideoxy-1,4-imino-D-arabinitol (DAB) or 1,4-dideoxy-1,4-imino-L-arabinitol (LAB) moiety held together via linkers of variable lengths containing a 1,2,3-triazole ring and 3, 4, or 7 CH(2) groups. The heterodimers were tested as inhibitors of butyrylcholinesterase (BuChE) and acetylcholinesterase (AChE). The enantiomeric heterodimers with the longest linkers exhibited the highest inhibition potencies for AChE (IC(50) = 9.7 nM and 11 nM) and BuChE (IC(50) = 8.1 nM and 9.1 nM). AChE exhibited the highest enantioselectivity (ca. 4-fold). The enantiomeric pairs of the heterodimers were found to be inactive (GI(50) > 100 µM), or to have weak antiproliferative properties (GI(50) = 84–97 µM) against a panel of human cancer cells.
format Online
Article
Text
id pubmed-9721440
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-97214402022-12-06 Investigation of the enantioselectivity of acetylcholinesterase and butyrylcholinesterase upon inhibition by tacrine-iminosugar heterodimers Vaaland, I. Caroline López, Óscar Puerta, Adrián Fernandes, Miguel X. Padrón, José M. Fernández-Bolaños, José G. Sydnes, Magne O. Lindbäck, Emil J Enzyme Inhib Med Chem Brief Report The copper-catalysed azide-alkyne cycloaddition was applied to prepare three enantiomeric pairs of heterodimers containing a tacrine residue and a 1,4-dideoxy-1,4-imino-D-arabinitol (DAB) or 1,4-dideoxy-1,4-imino-L-arabinitol (LAB) moiety held together via linkers of variable lengths containing a 1,2,3-triazole ring and 3, 4, or 7 CH(2) groups. The heterodimers were tested as inhibitors of butyrylcholinesterase (BuChE) and acetylcholinesterase (AChE). The enantiomeric heterodimers with the longest linkers exhibited the highest inhibition potencies for AChE (IC(50) = 9.7 nM and 11 nM) and BuChE (IC(50) = 8.1 nM and 9.1 nM). AChE exhibited the highest enantioselectivity (ca. 4-fold). The enantiomeric pairs of the heterodimers were found to be inactive (GI(50) > 100 µM), or to have weak antiproliferative properties (GI(50) = 84–97 µM) against a panel of human cancer cells. Taylor & Francis 2022-12-01 /pmc/articles/PMC9721440/ /pubmed/36458374 http://dx.doi.org/10.1080/14756366.2022.2150762 Text en © 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Brief Report
Vaaland, I. Caroline
López, Óscar
Puerta, Adrián
Fernandes, Miguel X.
Padrón, José M.
Fernández-Bolaños, José G.
Sydnes, Magne O.
Lindbäck, Emil
Investigation of the enantioselectivity of acetylcholinesterase and butyrylcholinesterase upon inhibition by tacrine-iminosugar heterodimers
title Investigation of the enantioselectivity of acetylcholinesterase and butyrylcholinesterase upon inhibition by tacrine-iminosugar heterodimers
title_full Investigation of the enantioselectivity of acetylcholinesterase and butyrylcholinesterase upon inhibition by tacrine-iminosugar heterodimers
title_fullStr Investigation of the enantioselectivity of acetylcholinesterase and butyrylcholinesterase upon inhibition by tacrine-iminosugar heterodimers
title_full_unstemmed Investigation of the enantioselectivity of acetylcholinesterase and butyrylcholinesterase upon inhibition by tacrine-iminosugar heterodimers
title_short Investigation of the enantioselectivity of acetylcholinesterase and butyrylcholinesterase upon inhibition by tacrine-iminosugar heterodimers
title_sort investigation of the enantioselectivity of acetylcholinesterase and butyrylcholinesterase upon inhibition by tacrine-iminosugar heterodimers
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9721440/
https://www.ncbi.nlm.nih.gov/pubmed/36458374
http://dx.doi.org/10.1080/14756366.2022.2150762
work_keys_str_mv AT vaalandicaroline investigationoftheenantioselectivityofacetylcholinesteraseandbutyrylcholinesteraseuponinhibitionbytacrineiminosugarheterodimers
AT lopezoscar investigationoftheenantioselectivityofacetylcholinesteraseandbutyrylcholinesteraseuponinhibitionbytacrineiminosugarheterodimers
AT puertaadrian investigationoftheenantioselectivityofacetylcholinesteraseandbutyrylcholinesteraseuponinhibitionbytacrineiminosugarheterodimers
AT fernandesmiguelx investigationoftheenantioselectivityofacetylcholinesteraseandbutyrylcholinesteraseuponinhibitionbytacrineiminosugarheterodimers
AT padronjosem investigationoftheenantioselectivityofacetylcholinesteraseandbutyrylcholinesteraseuponinhibitionbytacrineiminosugarheterodimers
AT fernandezbolanosjoseg investigationoftheenantioselectivityofacetylcholinesteraseandbutyrylcholinesteraseuponinhibitionbytacrineiminosugarheterodimers
AT sydnesmagneo investigationoftheenantioselectivityofacetylcholinesteraseandbutyrylcholinesteraseuponinhibitionbytacrineiminosugarheterodimers
AT lindbackemil investigationoftheenantioselectivityofacetylcholinesteraseandbutyrylcholinesteraseuponinhibitionbytacrineiminosugarheterodimers